Research Article

You have full text access to this OnlineOpen article

A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor

  1. R. L. Smeets,
  2. S. Veenbergen,
  3. O. J. Arntz,
  4. M. B. Bennink,
  5. L. A. B. Joosten,
  6. W. B. van den Berg,
  7. F. A. J. van de Loo*

Article first published online: 27 APR 2006

DOI: 10.1002/art.21752

Issue

Arthritis & Rheumatism

Arthritis & Rheumatism

Volume 54, Issue 5, pages 1518–1528, May 2006

Additional Information

How to Cite

Smeets, R. L., Veenbergen, S., Arntz, O. J., Bennink, M. B., Joosten, L. A. B., van den Berg, W. B. and van de Loo, F. A. J. (2006), A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor. Arthritis & Rheumatism, 54: 1518–1528. doi: 10.1002/art.21752

Author Information

  1. Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

*Radboud University Nijmegen Medical Centre, Nijmegen Center for Molecular Life Sciences, Geert Grooteplein 26-28, 6500 HB Nijmegen, The Netherlands

Publication History

  1. Issue published online: 27 APR 2006
  2. Article first published online: 27 APR 2006
  3. Manuscript Accepted: 5 JAN 2006
  4. Manuscript Received: 19 JUL 2005

Funded by

  • Dutch Arthritis Association. Grant Number: 01-1-304
  • VIDI fellowship from the Dutch Organization for Scientific Research. Grant Number: 917.46.363

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (647K)

REFERENCES

  • 1
    Van de Loo FA, Arntz OJ, van Enckevort FH, van Lent PL, van den Berg WB. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti–interleukin-1–treated wild-type mice with unabated joint inflammation. Arthritis Rheum 1998; 41: 634–46.
    Direct Link:
  • 2
    Joosten LA, Helsen MM, van de Loo FA, van den Berg WB. Anticytokine treatment of established type II collagen–induced arthritis in DBA/1 mice: a comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra. Arthritis Rheum 1996; 39: 797–809.
    Direct Link:
  • 3
    Luyten FP, Hascall VC, Nissley SP, Morales TI, Reddi AH. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 1988; 267: 416–25.
  • 4
    Curtis AJ, Ng CK, Handley CJ, Robinson HC. Effect of insulin-like growth factor-I on the synthesis and distribution of link protein and hyaluronan in explant cultures of articular cartilage. Biochim Biophys Acta 1992; 1135: 309–17.
  • 5
    Lazarus DD, Moldawer LL, Lowry SF. Insulin-like growth factor-1 activity is inhibited by interleukin-1α, tumor necrosis factor-α, and interleukin-6. Lymphokine Cytokine Res 1993; 12: 219–23.
  • 6
    Schalkwijk J, Joosten LA, van den Berg WB, van Wyk JJ, van de Putte LB. Insulin-like growth factor stimulation of chondrocyte proteoglycan synthesis by human synovial fluid. Arthritis Rheum 1989; 32: 66–71.
    Direct Link:
  • 7
    Joosten LA, Schalkwijk J, van den Berg WB, van de Putte LB. Chondrocyte unresponsiveness to insulin-like growth factor-1: a novel pathogenetic mechanisms for cartilage destruction in experimental arthritis. Agents Actions 1989; 26: 193–5.
  • 8
    Schalkwijk J, Joosten LA, van den Berg WB, van de Putte LB. Chondrocyte nonresponsiveness to insulin-like growth factor 1 in experimental arthritis. Arthritis Rheum 1989; 32: 894–900.
  • 9
    Verschure PJ, van Marle J, Joosten LA, van den Berg WB. Histochemical analysis of insulin-like growth factor-1 binding sites in mouse normal and experimentally induced arthritic articular cartilage. Histochem J 1996; 28: 13–23.
  • 10
    Verschure PJ, van Marle J, Joosten LA, van den Berg WB. Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis. Ann Rheum Dis 1995; 54: 645–53.
  • 11
    Dore S, Pelletier JP, DiBattista JA, Tardif G, Brazeau P, Martel-Pelletier J. Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation: possible role of IGF-1–binding proteins. Arthritis Rheum 1994; 37: 253–63.
    Direct Link:
  • 12
    Evans CH, Watkins SC, Stefanovic-Racic M. Nitric oxide and cartilage metabolism. Methods Enzymol 1996; 269: 75–88.
  • 13
    Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity [review]. Arthritis Rheum 1998; 41: 1141–51.
    Direct Link:
  • 14
    Hauselmann HJ, Oppliger L, Michel BA, Stefanovic-Racic M, Evans CH. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture. FEBS Lett 1994; 352: 361–4.
  • 15
    Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997; 324: 305–10.
  • 16
    Hauselmann HJ, Stefanovic-Racic M, Michel BA, Evans CH. Differences in nitric oxide production by superficial and deep human articular chondrocytes: implications for proteoglycan turnover in inflammatory joint diseases. J Immunol 1998; 160: 1444–8.
  • 17
    Studer RK, Levicoff E, Georgescu H, Miller L, Jaffurs D, Evans CH. Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IRβ tyrosine phosphorylation. Am J Physiol Cell Physiol 2000; 279: C961–9.
  • 18
    Alexander WS. Suppressors of cytokine signalling (SOCS) in the immune system. Nat Rev Immunol 2002; 2: 410–6.
  • 19
    Fujimoto M, Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol 2003; 24: 659–66.
  • 20
    Chartier C, Degryse E, Gantzer M, Dieterle A, Pavirani A, Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J Virol 1996; 70: 4805–10.
  • 21
    Erbacher P. Methods for adenovirus-mediated gene transfer to airway epithelium. In: RobbinsPD, editor. Methods in molecular medicine, gene therapy protocols. Totowa (NJ): Humana Press; 1997. p. 169–84.
  • 22
    Joosten LA, van de Loo FA, Lubberts E, Helsen MM, Netea MG, van der Meer JW, et al. An IFNγ-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 2000; 165: 6553–8.
  • 23
    Van de Loo FA, Kuiper S, van Enckevort FH, Arntz OJ, van den Berg WB. Interleukin-6 reduces cartilage destruction during experimental arthritis: a study in interleukin-6-deficient mice. Am J Pathol 1997; 151: 177–91.
  • 24
    Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–9.
  • 25
    Van Beuningen HM, Stoop R, Buma P, Takahashi N, van der Kraan PM, van den Berg WB. Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage. Osteoarthritis Cartilage 2002; 10: 977–86.
  • 26
    Shouda T, Yoshida T, Hanada T, Wakioka T, Oishi M, Miyoshi K, et al. Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. J Clin Invest 2001; 108: 1781–8.
  • 27
    De Hooge AS, van de Loo FA, Koenders MI, Bennink MB, Arntz OJ, Kolbe T, et al. Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum 2004; 50: 2014–23.
    Direct Link:
  • 28
    Studer RK, Decker K, Melhem S, Georgescu H. Nitric oxide inhibition of IGF-1 stimulated proteoglycan synthesis: role of cGMP. J Orthop Res 2003; 21: 914–21.
    Direct Link:
  • 29
    Studer RK. Nitric oxide decreases IGF-1 receptor function in vitro: glutathione depletion enhances this effect in vivo. Osteoarthritis Cartilage 2004; 12: 863–9.
  • 30
    Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1995; 146: 75–85.
  • 31
    Maneiro E, Lopez-Armada MJ, de Andres MC, Carames B, Martin MA, Bonilla A, et al. Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Ann Rheum Dis 2005; 64: 388–95.
  • 32
    Emanuelli B, Glondu M, Filloux C, Peraldi P, Van OE. The potential role of SOCS-3 in the interleukin-1β-induced desensitization of insulin signaling in pancreatic β-cells. Diabetes 2004; 53 Suppl 3: S97–103.
  • 33
    Emanuelli B, Peraldi P, Filloux C, Chavey C, Freidinger K, Hilton DJ, et al. SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J Biol Chem 2001; 276: 47944–9.
  • 34
    Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van OE. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 2000; 275: 15985–91.
  • 35
    Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, et al. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation. Proc Natl Acad Sci U S A 1999; 96: 2071–6.
  • 36
    Larsen L, Ropke C. Suppressors of cytokine signalling: SOCS. APMIS 2002; 110: 833–44.
    Direct Link:
  • 37
    Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387: 924–9.
  • 38
    Chadjichristos C, Ghayor C, Kypriotou M, Martin G, Renard E, la-Kokko L, et al. Sp1 and Sp3 transcription factors mediate interleukin-1β down-regulation of human type II collagen gene expression in articular chondrocytes. J Biol Chem 2003; 278: 39762–72.
  • 39
    Zaman K, Palmer LA, Doctor A, Hunt JF, Gaston B. Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1. Biochem J 2004; 380: 67–74.
View Full Article (HTML) Get PDF (647K)